About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5823 record(s)
Req # A-2019-000964
Any Contribution Agreements, initial or supplementary, between Health Canada and the Institute for Safe Medication Practices ("ISMP") pertaining to Health Canada's funding and ISMP's responsibilities related to the Canadian Medication Incident Reporting and Prevention System (CMIRPS) between January 1st, 2003 and August 30th, 2019.Organization: Health Canada
January 2020
Req # A-2019-001020
Module 1 and 2 contained in the Abbreviated New Drug Submission (ANDS) that is under review with Health Canada as at September 27, 2019 for a subsequent entry product containing the medicinal ingredient cladribine.Organization: Health Canada
January 2020
Req # A-2019-001021
The name of the sponsor and the date of submission for the Abbreviated New Drug Submission (ANDS) that is under review with Health Canada as at September 27, 2019 for a subsequent entry product containing the medicinal ingredient cladribine.Organization: Health Canada
January 2020
Req # A-2019-001024
In the year 2016, letter correspondence and emails sent by Health Canada to companies and/or trade associations regarding the implementation of the Plain Language Labelling Regulations (For prescription and non-prescription drugs).Organization: Health Canada
January 2020
Req # A-2019-001025
All records between Health Canada and the Standing Joint Committee on the Scrutiny of Regulations regarding the Plain Language Labelling Regulations from Jan. 1, 2016 - Oct. 1, 2019.Organization: Health Canada
January 2020
Req # A-2019-001097
All correspondence records between Health Canada and the Author(s) of "Systematic review of the association between perineal use of talc and ovarian cancer risk" for the period January 1, 2018 -- December 31, 2018.Organization: Health Canada
January 2020
Req # A-2019-001107
Provide statistical tables of drug losses reported to Health Canada from all New Brunswick hospitals and health centres from January 1, 2015 to September 30, 2019.Organization: Health Canada
January 2020
Req # A-2019-001176
Advise whether the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review on August 2017 has received either: a Notice of Deficiency (NOD); a Notice of Non-Compliance (NON); a NOD-Withdrawal (NOD-W) or a NON-Withdrawal (NON-W).Organization: Health Canada
January 2020
Req # A-2019-001180
Information as to whether or not the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017 is on “intellectual property hold??? as described in section 6.2 of Health Canada’s Guidance Document on Patented Medicines (Notice of Compliance) Regulations.Organization: Health Canada
January 2020
Req # A-2019-001222
All materials gathered in regards to a Health Canada investigation into the medical practice and clinic of Dr. Anthony Galea including images, documentation, receipts, accounts, and pharmaceutical records.Organization: Health Canada
January 2020